Biotech · Private company · Englewood, CO, US
Ampio Pharmaceuticals, Inc.
SEC CIK 0001411906
Track this companyFree. Adds Ampio Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials110 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- 4 mL injection of AmpionPhase 3 · Osteoarthritis, KneeClinicalTrials.gov · fetched Nov 12, 2026
- 4 mL injection of AmpionPhase 3 · Osteoarthritis of the KneeClinicalTrials.gov · fetched Nov 12, 2026
- 4 mL injection of AMPION™Phase 3 · Severe Osteoarthritis of the KneeClinicalTrials.gov · fetched Nov 12, 2026
- AmpionPhase 3 · Severe Osteoarthritis of the KneeClinicalTrials.gov · fetched Nov 12, 2026
- AmpionPhase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- AmpionPhase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- A Study to Evaluate Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID)PHASE1 · COMPLETED · started Jul 26, 2021ClinicalTrials.gov NCT04880161 · fetched Nov 12, 2026
- Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental OxygenPHASE2 · TERMINATED · started Jul 5, 2021ClinicalTrials.gov NCT04839965 · fetched Nov 12, 2026
- A Study of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19PHASE2 · TERMINATED · started Jun 22, 2021ClinicalTrials.gov NCT04868890 · fetched Nov 12, 2026
- Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory DistressPHASE1 · COMPLETED · started Oct 28, 2020ClinicalTrials.gov NCT04606784 · fetched Nov 12, 2026
- Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen SupplementationPHASE1 · COMPLETED · started Jul 27, 2020ClinicalTrials.gov NCT04456452 · fetched Nov 12, 2026
- Study of Ampion for the Treatment of Pain and Function in Patients With Severe Osteoarthritis of the Knee.PHASE3 · TERMINATED · started Jun 24, 2019ClinicalTrials.gov NCT03988023 · fetched Nov 12, 2026
- Open Label Extension to Assess the Safety of Long-Term Treatment With Ampion for Severe Osteoarthritis (OA) of the KneePHASE3 · TERMINATED · started Dec 8, 2017ClinicalTrials.gov NCT03349645 · fetched Nov 12, 2026
- AP-003-C Study to Confirm the Efficacy of Ampion™ in Adults With Pain Due to Severe Osteoarthritis of the KneePHASE3 · COMPLETED · started Jun 19, 2017ClinicalTrials.gov NCT03182686 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy & Safety of an Intra-Articular Ampion Injection for Pain of Osteoarthritis of the KneePHASE3 · COMPLETED · started Sep 1, 2015ClinicalTrials.gov NCT02556710 · fetched Nov 12, 2026
- A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in OsteoarthritisPHASE3 · COMPLETED · started Sep 1, 2014ClinicalTrials.gov NCT02242435 · fetched Nov 12, 2026
- A Study to Evaluate Safety of Three Intra-articular Injections of Ampion in the Knee of Adults With Osteoarthritis PainPHASE1_PHASE2 · COMPLETED · started Jun 1, 2014ClinicalTrials.gov NCT02184156 · fetched Nov 12, 2026
SEC filings1
- 8-K · FORM 8-KSEC EDGAR · filed Jan 29, 2025 · fetched Nov 12, 2026